• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Hep B reactivation common after liver resection for HBV-related hepatocellular carcinoma

bys25qthea
March 3, 2013
in Gastroenterology, Oncology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. Liver failure was more frequent in post-hepatectomy patients with HBV reactivation, resulting in shorter 3-year disease-free survival and overall survival.

2. Prophylactic antiviral treatment is protective against HBV reactivation.

Routine prophylactic antiviral treatment should be used for patients with hepatocellular carcinoma associated with Hepatitis B. If administered prior to partial liver resection, this prophylaxis lowers the risk of HBV reactivation, which is associated with shorter intermediate disease-free and overall survival. This study is limited by its retrospective nature and lack of randomization. The true effectiveness of HBV prophylaxis for prolonging post-hepatectomy survival should be evaluated by a randomized, controlled, multi-center trial. The authors identified multiple risk factors for HBV reactivation, disease-free survival, and overall survival that can be further studied prospectively. Finally, preoperative prophylaxis is a relatively low-risk intervention that can be immediately used in this patient population resulting in a potential 20-month increase in overall median survival.

Click to read the study in Annals of Surgery

RELATED REPORTS

OPTN and UNOS update policy regarding hepatocellular carcinoma [Classics Series]

Radiofrequency thermal ablation superior to percutaneous ethanol injection in hepatocellular carcinoma [Classics Series]

Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]

[/tab]

[tab]

Image: PD

1. Liver failure was more frequent in posthepatectomy patients with HBV reactivation, resulting in shorter 3-year disease-free survival and overall survival.

2. Prophylactic antiviral treatment is protective against HBV reactivation.

This [retrospective] study examined over two and a half thousand patients with hepatocellular carcinoma and a positive Hepatitis B surface antigen who underwent a liver resection. This study assessed the rate of HBV reactivation post-operatively, demonstrating that it was high even for patients with a low preoperative HBV DNA level. The risk factors that independently influenced HBV reactivation were viral markers such as positive Hepatitis B E Antigen (a sign of high viral replication), preoperative HBV-DNA levels over 200 and high inflammation as well as characteristics of the surgery such as preoperative transarterial chemoemboliztion, long operation time, and blood transfusion. Prophylactic therapy with antivirals such as lamivudine was found to be protective against HBV reactivation. Hepatitis B reactivation was found to be a significant independent risk factor for lower disease-free survival rate at three years and overall survival.

In sum: Routine prophylactic antiviral treatment should be used for patients with hepatocellular carcinoma associated with Hepatitis B. If administered prior to partial liver resection, this prophylaxis lowers the risk of HBV reactivation, which is associated with shorter intermediate disease-free and overall survival. This study is limited by its retrospective nature and lack of randomization. The true effectiveness of HBV prophylaxis for prolonging post-hepatectomy survival should be evaluated by a randomized, controlled, multi-center trial. The authors identified multiple risk factors for HBV reactivation, disease-free survival, and overall survival that can be further studied prospectively. Finally, preoperative prophylaxis is a relatively low-risk intervention that can be immediately used in this patient population resulting in a potential 20-month increase in overall median survival.

Click to read the study in Annals of Surgery

By Asya Ofshteyn and Allen Ho

More from this author: Post-operative PTSD intervention improves physical outcomes in trauma patients, Survival improved with lower transfusion threshold in acute upper intestinal bleeds, Single-port appendectomy shows similar outcomes to conventional laparoscopy

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: carcinomaHBVhepatitishepatocellular carcinoma
Previous Post

After-school program increases physical activity in overweight children

Next Post

Federal nutrition program does not increase childhood obesity risk

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

OPTN and UNOS update policy regarding hepatocellular carcinoma [Classics Series]

June 30, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

Radiofrequency thermal ablation superior to percutaneous ethanol injection in hepatocellular carcinoma [Classics Series]

June 30, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]

June 29, 2022
Large spike in drug use-associated infective endocarditis linked with opioid epidemic
Gastroenterology

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

March 17, 2022
Next Post
Federal nutrition program does not increase childhood obesity risk

Federal nutrition program does not increase childhood obesity risk

[Policy Statement] New guidelines for pediatric acute otitis media released

[Policy Statement] New guidelines for pediatric acute otitis media released

The MADIT-II trial: Prophylactic defibrillators improve survival in patients with myocardial infarction and left ventricular dysfunction

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.